APP
IMUC

Avantax Planning Partners’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Avantax Planning Partners’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-74
Closed – – 1480
2018
Q3 		$0 Buy
+74
New – ﹤0.01% 1479
2018
Q2 		– Sell
-74
Closed – – 1883
2018
Q1 		$0 Buy
+74
New – ﹤0.01% 1904